Pepfar 3.0's HIV testing policy in Cote d'Ivoire (2014 to 2018): fragmentation, acceleration and disconnection

被引:2
作者
Bekelynck, Anne [1 ,2 ,4 ]
Larmarange, Joseph [2 ,3 ,8 ]
Assoumou, Nelly [4 ]
Danel, Christine [4 ]
Doumbia, Mohamed [5 ]
Kone, Mariatou [5 ]
Kouadio, Alexis [5 ]
Kra, Arsene [4 ]
Niangoran, Serge [4 ]
Ouantchi, Honore [5 ]
Sika, Lazare [6 ]
Carillon, Severine [7 ]
Ingheis, Maxime [7 ]
机构
[1] Treichville Univ Hosp, PAC CI ANRS Res Site Program, Abidjan, Cote Ivoire
[2] Univ Paris 05, Ctr Populat & Developpement Ceped, INSERM, IRD, Paris, France
[3] IRD, Paris, France
[4] PAC CI, Abidjan, Cote Ivoire
[5] Inst Ethnosociol, Abidjan, Cote Ivoire
[6] ENSEA, Cergy, France
[7] Ceped, Paris, France
[8] IRD, Ceped, Paris, France
关键词
Pepfar; HIV testing; Health policy; COP (Country operational Plan); Cote d'Ivoire; Africa; ANTIRETROVIRAL THERAPY; TRANSMISSION; IMPACT; INTERVENTIONS; CRISIS;
D O I
10.1002/jia2.25424
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction HIV Testing and Counselling (HTC) remains a key challenge in achieving control of the HIV epidemic by 2030. In the early 2010s, the President's Emergency Plan for AIDS Relief (Pepfar) adopted targeted HTC strategies for populations and geographical areas most affected by HIV. We examine how Pepfar defined targeted HTC in Cote d'Ivoire, a country with a mixed HIV epidemic, after a decade of expanding HTC services. Methods We explored the evolution of HTC strategies through the Country Operational Plans (COP) of Pepfar during its phase 3.0, from COP 14 to COP 17 (October 2014 to September 2018) in Cote d'Ivoire. We conducted an analysis of the grey literature over the period 2014 to 2018 (Budget & Target Report, Strategic Direction Summary, Sustainability Index and Dashboard Summary, ). We also conducted a qualitative study in Cote d'Ivoire (2015 to 2018) using in-depth interviews with stakeholders in the AIDS public response: CDC/Pepfar (3), Ministry of Health (3), intermediary NGOs (7); and public meeting observations (14). Results Since the COP 14, Pepfar's HIV testing strategies have been characterized by significant variations in terms of numerical, geographical and population targets. While the aim of COP 14 and COP 15 seemed to be the improvement of testing efficacy in general and testing yield in particular, COP 16 and COP 17 prioritized accelerating progress towards the "first 90" (i.e. reducing the proportion of people living with HIV who are unaware of their HIV). A shift was observed in the definition of testing targets, with less focus on the inclusion of programmatic data and feedback from field actors, and greater emphasis on the use of models to estimate and disaggregate the targets by geographical units and sub-populations (even if the availability of data by this disaggregation was limited or uncertain); increasingly leading to gaps between targets and results. Conclusions These trials and tribulations question the real and long-term effectiveness of annually-revised, fragmented strategies, which widen an increasing disparity between the realities of the actors on the ground and the objectives set in Washington.
引用
收藏
页数:7
相关论文
共 42 条
  • [21] From emergency to sustainability: shifting objectives in the US Government's HIV response in Tanzania
    Marten, Meredith G.
    [J]. GLOBAL PUBLIC HEALTH, 2017, 12 (08) : 988 - 1003
  • [22] "What Took You So Long?" The Impact of PEPFAR on the Expansion of HIV Testing and Counseling Services in Africa
    Marum, Elizabeth
    Taegtmeyer, Miriam
    Parekh, Bharat
    Mugo, Nelly
    Lembariti, Salama
    Phiri, Mannasseh
    Moore, Jan
    Cheng, Alison S.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 60 : S63 - S69
  • [23] Ministere de la Sante et de l'Hygiene Publique, 2010, DOC POL NORM PROC CO
  • [24] Ministry of Health Cote d'Ivoire, 2018, COT IV POP BAS HIV I
  • [25] Implementation Science for the US President's Emergency Plan for AIDS Relief (PEPFAR)
    Padian, Nancy S.
    Holmes, Charles B.
    Mccoy, Sandra I.
    Lyerla, Rob
    Bouey, Paul D.
    Goosby, Eric P.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 (03) : 199 - 203
  • [26] Pepfar, 2012, PEPF BLUEPR CREAT AI
  • [27] Pepfar, 2009, PRES EM PLAN AIDS RE
  • [28] Pepfar TO of the USGAC (OGAC), 2014, PEPF 3 0 CONTR EP DE
  • [29] Beyond Indicators: Advances in Global HIV Monitoring and Evaluation During the PEPFAR Era
    Porter, Laura E.
    Bouey, Paul D.
    Curtis, Sian
    Hochgesang, Mindy
    Idele, Priscilla
    Jefferson, Bobby
    Lemma, Wuleta
    Myrick, Roger
    Nuwagaba-Biribonwoha, Harriet
    Prybylski, Dimitri
    Souteyrand, Yves
    Tulli, Tuhuma
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 60 : S120 - S126
  • [30] Unaids, 2018, UN DAT 2018